Silpa Kilaru, MD
Pulmonary and Critical Care Medicine
Accepting New Patients
Schedule an Appointment
Silpa Kilaru, MD, is a pulmonary and critical care physician at University Hospitals. She is board certified in critical care medicine and pulmonary disease and has special expertise in bronchoscopy and lung transplantation.
A Cleveland native, Dr. Kilaru earned her undergraduate degree from Columbia University in New York and her medical degree from The Ohio State University College of Medicine and Public Health in Columbus, Ohio. She completed an internship and residency in internal medicine as well as a fellowship in pulmonary/critical care medicine at Georgetown University in Washington D.C. Prior to joining UH, Dr. Kilaru was a pulmonary and critical care physician at the University of Pittsburgh Medical Center in Pittsburgh.
Dr. Kilaru is a member of several professional and scientific organizations, including the American College of Chest Physicians, the American Thoracic Society and the International Society of Heart and Lung Transplantation. She has been an invited presenter/lecturer at regional, national and international professional meetings and conferences.
- Lung Transplantation
Certifications & Memberships
- Critical Care Medicine - American Board of Internal Medicine
- Pulmonary Disease - American Board of Internal Medicine
Fellowship | Pulmonary/Critical Care
Pulmonary/Critical Care - Georgetown University (2009 - 2012)
Residency | Internal Medicine
Internal Medicine - Georgetown University (2007 - 2009)
Internship | Internal Medicine
Internal Medicine - Georgetown University (2006 - 2007)
The Ohio State University Wexner Medical Center (2002 - 2006)
Columbia University (2002)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Silpa Kilaru did not disclose any Outside Relationships with Industry.